MEDICINES CO (MDCO) Stock News
NASDAQ:MDCO - Nasdaq -
MDCO Latest News, Press Relases and Analysis
Q4 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios
The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and...
The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Jan. 2) Agile Therapeutics Inc (...
Why Meritor Shares Popped 16% Tuesday Morning
News that Meritor will be replacing The Medicines Company in the S&P SmallCap 600 index is pushing the stock higher Tuesday.
3 Biotech Stocks Likely to Maintain Solid Momentum in 2020
With the biotech sector gaining steam in recent times, we shortlist three biotech stocks that are set to maintain momentum in 2020.
NexPoint Residential Trust and Meritor Set to Join S&P SmallCap 600
Best Stocks 2019: Innovation, As Usual, Wins The Day — Or Even The Year
Throughout the year's list of the best stocks of 2019, there is an undercurrent of groundbreaking products and services that shape the way we live.
What to Expect from Amgen and Regeneron Stock in 2020, According to an Analyst
In notes on Monday afternoon, Raymond James analyst Dane Leone initiated coverage of Regeneron Pharmaceuticals and Amgen at Market Perform, writing that the current valuation of each of the stocks is fair.
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
Sector ETF report for PSCH
Alnylam's Kidney Disease Drug Succeeds in Late Stage Study
Alnylam (ALNY) reports positive top-line results from the phase III study on lumasiran for the treatment of primary hyperoxaluria type 1.
Deep Dive: Here’s how Wall Street’s favorite stock picks turned out in 2019
Their small-cap selections fared best.
How Wall Street’s top 2019 stock picks have panned out
Their small-cap selections fared best.
Deep Dive: Here’s how Wall Street’s favorite stock picks turned out in 2019
Their small-cap selections fared best.
5 Biotech Stocks That Have More Than Doubled This Year
The biotech sector has had a good run in 2019 on the back of ongoing M&A activities and positive pipeline updates.
Biotech Stocks Burn A Hole In Big Pharma's Pocket. Look For More In 2020
Mergers and acquisitions have lit up biotech stocks, and the hot pace shows no sign of slowing in 2020. Gene therapy and oncology companies are targets.
: There’s more upside for biotech even after 24% gains in two months
Seven biotech stocks to consider buying.
Why Biotech ETFs are Surging to New Highs
increasing M&A deals and cutting edge therapies are driving biotech ETFs higher
Can Cannabis 2.0 Kickstart Marijuana Stocks?
Marijuana beverages, edibles, and vapes are finally available in Canada, but marijuana stocks still have big obstacles to overcome.
This Gene Therapy Player Just Grabbed A $3 Billion Takeover Bid
Japanese pharma company Astellas Pharma is acquiring gene therapy biotech company Audentes for $3 billion. The deal values Audentes stock at $60 a share.
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of THE MEDICINES COMPANY - MDCO
30 momentum stocks that are actually cheap enough to buy
Look at the holdings of the Hennessy Cornerstone Mid Cap 30 Fund.